James E Wagner Cultivation Corp
James E. Wagner Cultivation Corporation, through its subsidiary, James E. Wagner Cultivation Ltd., engages in the cultivation and sale of medical cannabis in Canada. The company focuses on producing clean, consistent cannabis using a proprietary aeroponic platform named GrowthSTORM. James E. Wagner Cultivation Corporation was founded in 2007 and is headquartered in Kitchener, Canada.
James E Wagner Cultivation Corp (JWCAF) - Net Assets
Latest net assets as of December 2019: $14.87 Million USD
Based on the latest financial reports, James E Wagner Cultivation Corp (JWCAF) has net assets worth $14.87 Million USD as of December 2019.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($40.76 Million) and total liabilities ($25.89 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $14.87 Million |
| % of Total Assets | 36.48% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 140.48 |
James E Wagner Cultivation Corp - Net Assets Trend (2016–2019)
This chart illustrates how James E Wagner Cultivation Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for James E Wagner Cultivation Corp (2016–2019)
The table below shows the annual net assets of James E Wagner Cultivation Corp from 2016 to 2019.
| Year | Net Assets | Change |
|---|---|---|
| 2019-09-30 | $11.41 Million | -41.88% |
| 2018-09-30 | $19.64 Million | +239.07% |
| 2017-09-30 | $5.79 Million | +1612.75% |
| 2016-09-30 | $-382.88K | -- |
Equity Component Analysis
This analysis shows how different components contribute to James E Wagner Cultivation Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1725908296.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2019)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $27.84 Million | 243.92% |
| Other Comprehensive Income | $29.74 Million | 260.54% |
| Total Equity | $11.41 Million | 100.00% |
James E Wagner Cultivation Corp Competitors by Market Cap
The table below lists competitors of James E Wagner Cultivation Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ilshinstone Co. Ltd.
KQ:007110
|
$10.18K |
|
ALMUNDA PROFESSIONAL
AS:AMUND
|
$10.18K |
|
413300
KO:413300
|
$10.20K |
|
SAVANT EXPL
BE:8SX
|
$10.21K |
|
Fundusz Hipoteczny Dom SA
WAR:FHD
|
$10.17K |
|
Metrics Income Opportunities Trust
AU:MOT
|
$10.16K |
|
CHINA OILFIELD -H-
MU:CO9
|
$10.16K |
|
Matritense Real Estate SOCIMI S.A.
MC:YMAT
|
$10.15K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in James E Wagner Cultivation Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2018 to 2019, total equity changed from 19,639,468 to 11,413,812, a change of -8,225,656 (-41.9%).
- Net loss of 6,988,106 reduced equity.
- New share issuances of 4,271,283 increased equity.
- Other comprehensive income increased equity by 29,736,985.
- Other factors decreased equity by 35,245,818.
Equity Change Factors (2018 to 2019)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-6.99 Million | -61.23% |
| Share Issuances | $4.27 Million | +37.42% |
| Other Comprehensive Income | $29.74 Million | +260.54% |
| Other Changes | $-35.25 Million | -308.8% |
| Total Change | $- | -41.88% |
Book Value vs Market Value Analysis
This analysis compares James E Wagner Cultivation Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-09-30 | $0.00 | $0.00 | x |
| 2017-09-30 | $0.00 | $0.00 | x |
| 2018-09-30 | $0.27 | $0.00 | x |
| 2019-09-30 | $0.12 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently James E Wagner Cultivation Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -61.23%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -327.95%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 1.92x
- Recent ROE (-61.23%) is below the historical average (-44.10%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-655.85K |
| 2017 | -62.66% | 0.00% | 0.00x | 1.48x | $-4.21 Million |
| 2018 | -52.52% | -17902.38% | 0.00x | 1.23x | $-12.28 Million |
| 2019 | -61.23% | -327.95% | 0.10x | 1.92x | $-8.13 Million |
Industry Comparison
This section compares James E Wagner Cultivation Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| James E Wagner Cultivation Corp (JWCAF) | $14.87 Million | 0.00% | 1.74x | $10.17K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |